Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec

References

• Statistics CanadaThe 10 leading causes of death2011 Available from: http://www.statcan.gc.ca/pub/82-625-x/2014001/article/11896-eng.htmAccessed February 9, 2017
   Google Scholar
• Public Health Agency of CanadaReport from the Canadian Chronic Disease Surveillance System: Hypertension in Canada2010 Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/ccdss-snsmc-2010/pdf/CCDSS_HTN_Report_FINAL_EN_20100513.pdfAccessed February 9, 2017
   Google Scholar
• HoPMBrysonCLRumsfeldJSMedication adherence: its importance in cardiovascular outcomesCirculation2009119233028303519528344
   PubMed Web of Science ®Google Scholar
• PadwalRStrausSEMcAlisterFAEvidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based reviewBMJ2001322729297798011312234
   PubMed Web of Science ®Google Scholar
• SavagePJPresselSLCurbJDInfluence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research GroupArch Intern Med199815877417519554680
   PubMedGoogle Scholar
• AronowWSFlegJLPepineCJACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of HypertensionJ Am Coll Cardiol201157202037211421524875
   PubMed Web of Science ®Google Scholar
• DrussBGMarcusSCOlfsonMTanielianTElinsonLPincusHAComparing the national economic burden of five chronic conditionsHealth Aff (Millwood)2001206233241
   PubMed Web of Science ®Google Scholar
• AbegundeDOMathersCDAdamTOrtegonMStrongKThe burden and costs of chronic diseases in low-income and middle-income countriesLancet200737096031929193818063029
   PubMed Web of Science ®Google Scholar
• SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
   PubMed Web of Science ®Google Scholar
• JoffresMRCampbellNRMannsBTuKEstimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in CanadaCan J Cardiol200723643744317487286
   PubMed Web of Science ®Google Scholar
• WalkerRLChenGCampbellNRCanadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006Can J Cardiol201127446146721640546
   PubMed Web of Science ®Google Scholar
• AlhaddadIAHamouiOHammoudehAMallatSTreatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherenceVasc Health Risk Manag20161240741327822055
   PubMed Web of Science ®Google Scholar
• Behnood-RodARabbanifarOPourzargarPAdherence to antihypertensive medications in Iranian PatientsInt J Hypertens20162016150875227069676
   PubMed Web of Science ®Google Scholar
• TamblynRLapriseRHanleyJAAdverse events associated with prescription drug cost-sharing among poor and elderly personsJAMA2001285442142911242426
   PubMed Web of Science ®Google Scholar
• MaciejewskiMLBrysonCLPerkinsMIncreasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medicationsAm J Manag Care2010161e20e3420059288
   PubMed Web of Science ®Google Scholar
• TairaDAWongKSFrech-TamasFChungRSCopayment level and compliance with antihypertensive medication: analysis and policy implications for managed careAm J Manag Care2006121167868317090224
   PubMed Web of Science ®Google Scholar
• Kamal-BahlSBriesacherBHow do incentive-based formularies influence drug selection and spending for hypertension?Health Aff (Millwood)200423122723615002647
   PubMed Web of Science ®Google Scholar
• BriesacherBALimcangcoMRFrech-TamasFNew-user persistence with antihypertensives and prescription drug cost-sharingJ Clin Hypertens (Greenwich)200791183183617978589
   PubMedGoogle Scholar
• YoonJEttnerSLCost-sharing and adherence to antihypertensives for low and high adherersAm J Manag Care2009151183384019895188
   PubMed Web of Science ®Google Scholar
• DespresFForgetAKettaniFZBlaisLImpact of patient reimbursement timing and patient out-of-pocket expenses on medication adherence in patients covered by private drug insurance plansJ Manag Care Spec Pharm201622553954727123915
   PubMed Web of Science ®Google Scholar
• KennedyJMorganSA cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of HealthClin Ther20062881217122416982299
   PubMed Web of Science ®Google Scholar
• TongXChuEKFangJWallHKAyalaCNonadherence to antihy-pertensive medication among hypertensive adults in the United States–HealthStyles, 2010J Clin Hypertens (Greenwich)201618989290026841710
   PubMed Web of Science ®Google Scholar
• LawMRChengLDhallaIAHeardDMorganSGThe effect of cost on adherence to prescription medications in CanadaCMAJ2012184329730222249979
   PubMed Web of Science ®Google Scholar
• KratzerJChengLAllinSLawMRThe impact of private insurance coverage on prescription drug use in Ontario, CanadaHealth Policy20151046274
   Google Scholar
• HurleyJMorganSUS Medicare reform: why drug companies and private insurers are smilingCMAJ2004170446146214970088
   PubMed Web of Science ®Google Scholar
• Health CanadaProvincial and territorial public drug benefit programs2017 Available from: http://www.hc-sc.gc.ca/hcs-sss/pharma/acces/ptprog-eng.phpAccessed February 9, 2017
   Google Scholar
• MedicareMedicare coverage (Part D) Available from: https://www.medicare.gov/part-d/index.htmlAccessed March 13, 2017
   Google Scholar
• KapurVBasuKDrug coverage in Canada: who is at risk?Health Policy200571218119315607380
   PubMed Web of Science ®Google Scholar
• MedicaidSeniors & Medicare and Medicaid Enrollees Available from: https://www.medicaid.gov/medicaid/eligibility/medicaid-enrollees/index.htmlAccessed March 13, 2017
   Google Scholar
• Régie de l’assurance maladie du QuébecLe régime général d’assurance médicaments Available from: https://www4.prod.ramq.gouv.qc.ca/IST/CD/CDF_DifsnInfoStats/CDF1_CnsulInfoStatsCNC_iut/Rapp-PDF.aspx?TypeImpression=pdf&NomPdf=CC_AMHist_0000_0_O.pdfAccessed February 9, 2017
   Google Scholar
• Régie de l’assurance maladie Du QuébecRapport annuel de gestion: 2010–20112011 Available from: http://www.ramq.gouv.qc.ca/SiteC-ollectionDocuments/citoyens/fr/rapports/rappann1011-fr.pdfAccessed February 9, 2017
   Google Scholar
• HessLMRaebelMAConnerDAMaloneDCMeasurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresAnn Pharmacother2006407–81280128816868217
   PubMed Web of Science ®Google Scholar
• MartinBCWiley-ExleyEKRichardsSDominoMECareyTSSleathBLContrasting measures of adherence with simple drug use, medication switching, and therapeutic duplicationAnn Pharmacother2009431364419126828
   PubMed Web of Science ®Google Scholar
• DawJRMorganSGStitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010Health Policy20121041192621978939
   PubMed Web of Science ®Google Scholar
• MorganSGDawJRLawMRRethinking Pharmacare in Canada2013C.D. Howe Institute Commentary 377 Available from: https://www.cdhowe.org/sites/default/files/attachments/research_papers/mixed/Commentary_384_0.pdfAccessed February 9, 2017
   Google Scholar
• MorganSGLawMDawJRAbrahamLMartinDEstimated cost of universal public coverage of prescription drugs in CanadaCMAJ2015187749149725780047
   PubMed Web of Science ®Google Scholar
• MorganSGLiWYauBPersaudNEstimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in CanadaCMAJ20171898E295E30228246223
   PubMed Web of Science ®Google Scholar
• ChristeVWaeberGVollenweiderPMarques-VidalPAntihypertensive drug treatment changes in the general population: the CoLaus studyBMC Pharmacol Toxicol2014152024685255
   PubMed Web of Science ®Google Scholar
• MazzagliaGMantovaniLGSturkenboomMCPatterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary careJ Hypertens200523112093210016208153
   PubMed Web of Science ®Google Scholar
• LeungAANerenbergKDaskalopoulouSSHypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of HypertensionCan J Cardiol201632556958827118291
   PubMed Web of Science ®Google Scholar
• OdubanjoEBennettKFeelyJInfluence of socioeconomic status on the quality of prescribing in the elderly – a population based studyBr J Clin Pharmacol200458549650215521897
   PubMed Web of Science ®Google Scholar
• MaherRLHanlonJHajjarERClinical consequences of polypharmacy in elderlyExpert Opin Drug Saf2014131576524073682
   PubMed Web of Science ®Google Scholar
• KovacevicSVMiljkovicBVucicevicKElderly polypharmacy patients’ needs and concerns regarding medication assessed using the structured patient-pharmacist consultation modelPatient Educ Couns Epub201751
   Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• GrymonpreREDidurCDMontgomeryPRSitarDSPill count, self-report, and pharmacy claims data to measure medication adherence in the elderlyAnn Pharmacother1998327–87497549681089
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to long-term therapies: evidence for action2003 Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdfAccessed February 9, 2017
   Google Scholar